Issue: December 2018
November 08, 2018
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
New in-office treatment addresses MGD
Issue: December 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN ANTONIO – Leslie O’Dell, OD, discussed here at the American Academy of Optometry meeting an up-and-coming product for patients with meibomian gland dysfunction (MGD), Sight Science’s Tear Care.
With the in-office treatment, the eyelids are comfortably heated, then the meibum is cleared from the glands. O’Dell said the patients she has treated report less awareness of their eyes, increased comfort and less eye fatigue.